Aside from the effects indicated above, FBXW7 downregulation also modulates the ubiquitination of related targets including cell cycle proteins G-associated kinase (GAK), p53, Aurora-B, γ-catenin, and CENP-A, which increases breast cancer cell cycle progression [21, 80–83]. This evidence concerns the gene TP53 and breast cancer.